Company Filing History:
Years Active: 2020
Title: Yongzhi Karen Cui: Innovator in Cancer Immunotherapy
Introduction
Yongzhi Karen Cui is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of cancer immunotherapy through his innovative research and development of chimeric antigen receptors (CARs). His work focuses on enhancing the immune system's ability to recognize and combat cancer cells.
Latest Patents
Yongzhi Karen Cui holds a patent for "Anti-CD276 chimeric antigen receptors." This patent discloses CARs that specifically bind to and immunologically recognize CD276. Additionally, it includes related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions associated with the polypeptides and proteins. The patent also outlines methods for detecting the presence of cancer in mammals, as well as methods for treating or preventing cancer in mammals.
Career Highlights
Cui is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.
Collaborations
One of his notable collaborators is Crystal L Mackall, who is also a prominent figure in cancer research. Their partnership exemplifies the collaborative spirit that drives innovation in the medical field.
Conclusion
Yongzhi Karen Cui's contributions to cancer immunotherapy through his patented innovations highlight the importance of research and collaboration in advancing medical science. His work continues to pave the way for new treatments that could significantly impact cancer care.